Harvard's T-cell cancer therapy developer has filed to list on the Nasdaq Global Market.

UK’s Ian McClure has been promoted to associate vice-president for research, innovation and economic impact, having previously been executive director of the tech transfer office.

Based on research at MIT, LiquiGlide has brought its overall funding to $50m following a $13.5m round.

University of Pennsylvania is working on a treatment for solid tumours and its only known investor is HLB Pharmaceutical.

University of California is among the limited partners for venture firm Congruent Ventures’ latest sustainability-focused fund that had a $125m target.

Deerfield Management has added Empire Discovery Institute to its ever-growing roster of partners for its drug discovery engine.

Max Planck spinout The Captury has been acquired by Dari Motion for an undisclosed amount.

University of Auckland’s Rain Therapeutics has priced shares at $17 each to raise $125m in its initial public offering.

University of Maryland’s Quantum Startup Foundry has been established with a $25m investment to support the development of quantum technologies.

Duke spinout Istari Oncology has collected $43.5m out of a targeted $70m for its latest round.